Family Medicine EOR Exam Flashcards
Stable Angina
Relieved by rest and/or NTG
Unstable Angina
Stable angina that increasingly occurs at rest and is more frequent
Prinzmetal angina
Coronary artery vasospasm causing transient ST-elevations
No clot
Narrow QRS complex with absent or inverted P wave
PJC - Premature Junctional Contraction
Narrow complex tachycardia with no discernable P waves
Paroxysmal supraventricular tachycardia
Sawtooth pattern with narrow QRS
Atrial flutter
Arrhythmia in which bradycardia alternates with tachycardia
Brady-tachy sick sinus syndrome
Sinus arrest
Absence of sinus activity for 3+ seconds
NSTEMI
St segment depression , t wave inversion, or both
Cardiac markers elevated!
STEMI
Elevated Cardiac biomarkers WITH ST segment elevation
Chest pain releived by sitting and leaning forward
Pericarditis
Severe tearing, ripping, knife like pain radiating to the back
Aortic dissection
Presentation of pulmonary embolism
Dyspnea is the MC symptom
Pleuritic chest pain
Best initial test for a PE
Spiral CT scan of the chest
Presentation of pulmonary hypertension
Dyspnea on exertion, fatigue, chest pain, edema and syncope
Murmur of pulmonary hypertension
Loud P2, systolic ejection click and parasternal lift
Dx for pulmonary hypertension
Right heart cath with mean pulmonary artery pressure above 25 mmHg
Criteria for rheumatic fever dx
2 major criteria or 1 major plus 2 minor
Titers of rheumatic fever
Elevated antistreptolysin titers (ASO)
Presentation of costochondritis
Pain with palpation or arm movement
Classic presentation of CHF
Exertional dyspnea progressing to at rest
Chronic nonproductive cough, worse when recumbent
Fatigue
Orthopnea
Nocturnal dyspnea
Nocturia
S4 in heart failure
DIastolic/ HFpEF
S3 in heart failure
COmpliant ventricle
Systolic/HFrEF
Physical exam signs of CHF
Cheyenne stokes breathing
Edema
Rales
S3 and S4
JVD over 8 cm
CYanosis/Coolness of extremities
Ascites
BNP for heart failure
Lower in obese patients
Differentiates SOB of HF from other SOB
CXR of heart failure
Kerley B Lines
Best test for CHF
ECHO!!!
NYHA Class I
No limitation of physical activity
NYHA class II
Slight limitation with physical activity but comfortable at rest
NYHA class III
Marked limitation of physical activity still comfortable at rest
NYHA class IV
Unable to carry on physical activity without discomfort AND have symptoms of angina at rest
Management for Systolic heart failure
ACEI, BB, Loop diuretic
NO CCB
Management for diastolic HF
ACEI with BB or Non-DHP-CCB
NO DIURETIC
Effect of morphine on HF
Reduces preload
Major CAD risk factors`
DM
Smoking
Hypertension
HLD
Family Hx
Over 45 for men and 55 for women
Potenital PE findings for ACS
Mitral regurg/S4
CHF symptoms (edema, crackles)
Signs of vascular disease (bruits, diminished pulses)
Why might we want a CXR in ACS
To rule out aortic dissection
Meds for use in ACS
MONA
May use ACEI
Drugs to improve mortality post MI - 4 and 1 NOT TO USE
Antiplatelet (Aspirin or Plavix)
Beta blocker
ACE or ARB
Statin
NO CCB’s
Presentation of endocarditis
Fever with a new onset heart murmur
MCC pathogen in Acute, Subacuite, IVDU, and prosthetic valve endocarditis
Acute and IVDU - Staph aureus
Subacute S. viridans
Prostetic valve - S epidermitis
Major Dukes criteria for endocarditis - 3
2 positive blood cultures 12 hours apart (staph for drug users strep for non drug users)
Vegetations are seen on Echo (tricuspid-IV drug users, mitral-non drug users
New regurg murmur
Minor Dukes criteria for endocarditis 2 + 4 skin signs
Risk factor
Fever 100.5
Splinter hemorrhages,
Janeway lesions
Osler node
Roth spots
Janeway lesions
Painless lesions, palms and soles. Assoc with endocarditis
Flat macules
Osler Node
Raised painful tender immunologic lesion assoc with endocarditis
Ouchy nodes!
Roth spots
Exudative lesions on the retina assoc with endocarditis. Immunologic
Diagnostic Duke criteria for endocarditis
2 major criteria, or
1 major and 3 minor criteria, or
5 minor criteria
Tx for infective endocarditis
IV vancomycin or ampicillin/sulbactam PLUS aminoglycoside
Drug to add to endocarditis for those with prosthetic valves
Rifampin
Prophylaxis for endocarditis in dental surgeries
Amoxicillin - 2 g 30-60 minutes before the procedure
USPSTF HLD screening guideline
Start at 35 for ALL adults
4 statin benefit groups
Patients with any form of clinical atherosclerotic cardiovascular disease (ASCVD)
Patients with primary LDL-C levels of 190 mg per dL or greater
Patients WITH diabetes mellitus, 40 to 75 years of age, with LDL-C levels of 70 to 189 mg per dL
Patients WITHOUT diabetes, 40 to 75 years of age, with an estimated 10-year ASCVD risk ≥ 7.5%
Statin for benefit group 1 - Patients with ASCVD
High intensity statin if under 75
Evaluate risk/benefit if over 75
Statin for benefit group 2 - LDL-C of 190+ or triglycerides over 500
High intensity statin, try to reduce LDL by 50%
Statin for benefit group 3 - WITH diabetes mellitus, 40 to 75 years of age, with LDL-C levels of 70 to 189
Moderate intensity if ASCVD risk under 7.5%
High intensity if ASCVD risk 7.5%+
RIsk benefit for out of age range
Statin for benefit group 4 - WITHOUT diabetes, 40 to 75 years of age, with an estimated 10-year ASCVD risk ≥ 7.5%
Moderate to high intensity
Moderate if risk is 5-7.5%
Lipid goals for LDL, HDL, and Total cholesterol
LDL under 100
Total under 200
HDL over 60
2 high intensity statins
Atorvastatin 40-80mg
Rosuvastatin 20-40mg
5 Low intensity statins
Simvastatin 10
Pravastatin 10-20
Lovastatin 20
Fluvastatin 20-40
Pitavistatin 1 mg (you read that right)
Elevated blood pressure
120-129 with DBP under 80
Stage 1 hypertension
130-139 with DBP 80-89
Stage 2 HTN
140+/90+
Elevated peds BP
SBP and/or DBP ≥90th percentile but <95th percentile, or 120/80 mmHg to <95th percentile (whichever is lower)
Stage 1 HTN for peds
SBP and/or DBP ≥95th percentile to <95th percentile + 12 mmHg, or 130/80 to 139/89 mmHg
Stage 2 HTN for peds
SBP and/or DBP ≥95th percentile + 12 mmHg, or ≥ 140/90 mmHg (whichever is lower)
ACC/AHA BP target
130/80
Tx guidelines for normal BP
Evaluate yearly, encourage healthy lifestyle
Tx guidelines for elevated BP
Lifestyle changes with 3-6 month reassessment
Management for Stage 1 hypertension with ASCVD risk <10%
Lifestyle management with 3-6 month follow up
Management for Stage 1 hypertension with ASCVD risk >10% or w/ CVD, DM, CKD
1 medication with 1 month follow up
Monthly follow up with adjustment until goal BP is met; 3-6 month follow up after that
Management for stage 2 HTN
2 BP medications with 1 month followed with monthly f/u until goal met then 3-6 month f/u
Initial agents for HTN treatment
ACE or ARB
Thiazide diuretic (chlorthalidone)
Long acting CCB (amlodipine)
Initial agents for HTN in African Americans
CCB and/or Thiazide diuretics
Contraindication for CCBs
Angina pectoris
Can cause leg edema
ACE/ARB contraindications
Diabetes with proteinuria
ACE specific contraindication
Cough and hyperkalemia
COntraindicated in pregnancy
Contrindication for spironolactone
Hyperkalemia
Contraindications for beta blockers
Asthma, may cause impotence
Hypertensive urgency
180/120+ BP without hypertensive urgency
Patients whould start a 2 drug regimen with frequent follow up
End organ damage signs that make it a hypertensive emergency - 7
(BP 180/120+)
retinal hemorrhages/ papilledema encephalopathy,
acute and subacute kidney injury,
intracranial hemorrhage,
aortic dissection,
pulmonary edema,
unstable angina or MI
Management for hypertensive emergency
In the first hour reduce by 10-20 percent
Reduce by 5-15 percent over then next 23 hours
First hour goal is generally under 180/120
24 hour goal is usually under 160/110
Management for hypertensive emergency with retinopathy or encephalopathy
Rapidly lower the mean arterial pressure by approximately 10 to 15 percent in the first hour and by no more than 25 percent compared with baseline by the end of the first day of treatment
Gradually reduce to under 130/80 over 2-3 months
Drug of choice for hypertensive urgency
Clonidine
Drug of choice for hypertensive emergency
Sodium nitroprusside
Drugs of choice for hypertenve emergency with retinopathy/encephalopathy
Sodium nitroprusside or clevidipine
Upper limits of normal, moderate, moderate to severe, and severe hypertriglyceridemia
Under 150
150-499
500-999
1000+
NCEP triglyceride screen recommendation
Beginning at 20 every 5 years. Fasting is best but may be non-fasting in healthy asymptomatic individuals
Yearly for CHD equivalent with fasting
Fasting should be 12-16 hours to confirm reading
Management option for hypertriglyceridemia
Lower below 500 to prevent pancreatitis
Fibrates and Niacin is isolated
Lipitor and FIsh oil may also help
Aspirin may help with HDL
Side effect of niacin administraction
May cause hyperglycemia
Presentation of intermittent claudication
Dull aching pain and numbness worse with exercise and relieved with rest
Thin skin, hair loss, and numbness of extremities
Diagnosis for intermittent claudication
ABI less than or equal to 0.9
Angiography is the gold standard
Management for intermittent claudication
Stop smoking - first line
Graduated exercise conditioning
May do angioplasty or bypass
3 meds for intermittent claudication
ASA
Clopidogrel
CIlostazol
Patients who need PAD screening
Over 70
Abnormal or absent pedal pulse
Aged 50-69 with smoking hx or DM
ABI range for no further testing
0.9-1.3
Management for asymptomatic PAD
Statin
ASA
Blood pressure control
Symptomatic PAD or PVD
Cramping, intermittent claudication with rest pain and muscle atrophy, thick toenails, hair loss
Diminished pulses
Diagnostics for PAD or PVD
ABI (0.9 or under diagnostic)
Doppler
Arteriography - Gold standard
Management of PAD or PVD
Manage chronic conditions and smoking
Graduated exercise
ASA, Cilostazol, Plavix
Best sugical management for PAD/PVD
Angioplasty is preferred
Cilostazol
Pletal - PDE-5 inhibito for peripheral vascular disease
Mitral valve location
Between left ventricle and atrium
Erbs point
Third left ICS, L sternal border
Murmur of aortic stenosis
Systolic ejection crescendo-decrescendo at the right upper sternal border
1st post with radiation to the neck
Split S2
Presentation of Aortic stenosis
Murmur is worse with squatting and expiration
Murmur decreases with valsalva
Syncope and LVH
Murmur of Aortic regurg
Early diastolic, soft-blowing decrescendo murmur with a high-pitch quality, especially when the patient is sitting and leaning forward heard at the left lower sternal border
Presentation of aortic regurg
Increases with squatting, decreases with valsalva
History of congenital heart defect or rheumatic fever
Murmur of mitral stenosis
Rumbling diastolic murmur with a split s1 that occurs following an opening snap. The rumbling is loudest at the start of diastole and is heard best at the left sternal border and apex
Presentation of mitral stenosis
Opening snap and murmur at LLSB/Apex
Left atrial hypertrophy - golden arches P wave on EKG lead II
SOB and CHF from fluid backup
Increase with squatting, decreases with valsalva
Murmur of mitral regurg
Blowing HOLOSYSTOLIC murmur at APEX with a SPLIT S2, radiates to the axilla
Presentation of mitral regurg
Previous STEMI
Low BP with tachycardia
Lung crackles
Murmur of pulmonic stenosis
Harsh systolic murmur best heard at the second and third left intercostal space; it radiates to the left shoulder
Presentation of pulmonic stenosis
SOB with split S2 and RVH
JVD. Increases with squatting and inspiration, decreases with valsalva
Murmur increase and expiration/inspiration
Right heart murmurs increase with inspiration
Left heart murmurs increase with expiration
Murmur of pulmonic regurgitation
High pitched diastolic decrescendo murmur at the LUSB that increases with inspiration
Presentation of pulmonic regurg
SOB and DOE
Increases with inspiration and squatting
Decreases with valsalva
Hand grip
Maneuver that only challenges aortic valve